Premium respiratory protection solutions business CleanSpace Holdings (ASX: CSX) is confident it can maintain its current strong growth, forecasting an increase in sales in the 2025 financial year and beyond.
CleanSpace reported revenue of $9.2 million for H1 FY25, representing growth of 26% compared to the previous corresponding period (pcp).
The company’s gross margin increased 3% to 74% due to a positive mix and manufacturing efficiencies, with a 6% fall in expenses reflecting consistent cost control.
The company said it registered broad-based growth in all regions and focus countries.
Sales from Europe contributed 58% of total revenue, with growth of 11% on the pcp, while France remained CleanSpace’s largest-selling country despite recording slower growth of 2% due to the impact of the Olympics and Paralympics.
The UK recorded 44% growth, while the Nordics (+28%) also grew significantly.
Revenue in the Asia-Pacific and Rest of the World divisions was up 37% sequentially against the prior half.
Growth was driven by a solid result in Australia (+8% versus the pcp), while the company’s strategy to expand into Asia delivered a $0.4m sales increase.
North America contributed 13% of H1 FY25 revenue, with 31% growth on the pcp.
The company noted that its balance sheet remains strong, with $8.3m cash on hand as of 31 December 2024 and anticipates receipt of a research and development rebate in the vicinity of $1m sometime during the second half.
CleanSpace remains confident that the current outlook for revenue growth and cost/cash initiatives will support profitable growth and positive cash flow in the medium term.
“CleanSpace is well positioned to continue sales growth of 25-30% in FY25 and beyond, focused on our priority markets, with strong revenue momentum expected in all three regions,” the company stated.
The company estimates its total addressable market currently sits at $3b, with an estimated annual growth rate of between 6% and 8%.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.